Concepedia

Mikael Dolsten

MD

Statistics

Publications

6

Citations

445

H-Index

6

Active since

2012

Affiliations

Pfizer (United States)(Current)

Mikael Dolsten is an author at Pfizer (United States) specializing in medicine, pharmacology, and toxicology.

ORCID

Top concepts

Publications per year

2012–2024

6

Publications

6

Healthcare on the brink: navigating the challenges of an aging society in the United States

Charles H. Jones, Mikael Dolsten · npj Aging · 2024 · 210 citations · Full text

Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir

Emily S. Ford, William Simmons, Ellora Karmarkar et al. · Clinical Infectious Diseases · 2022 · 69 citations · Full text

Achieving end-to-end success in the clinic: Pfizer’s learnings on R&D productivity

Kathy Fernando, Sandeep Menon, Kathrin U. Jansen et al. · Drug Discovery Today · 2021 · 50 citations · Full text

, , +21

Breaking the mold with RNA—a “RNAissance” of life science

Charles H. Jones, John R. Androsavich, N. So et al. · npj Genomic Medicine · 2024 · 42 citations · Full text

Precision medicine: an approach to R&D for delivering superior medicines to patients

Mikael Dolsten, Morten Søgaard · Clinical and Translational Medicine · 2012 · 38 citations · Full text

1–5 of 6